Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus

Published:2018-09-14 Issue:10 Volume:72 Page:e13240
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Nauck Michael¹,Araki Atsushi²,Hehnke Uwe³,Plat Arian³⁴,Clark Douglas³,Khunti Kamlesh⁵

Affiliation:

1. Diabetes Center Bochum-Hattingen; St. Josef-Hospital; Ruhr-University Bochum; Bochum Germany

2. Tokyo Metropolitan Geriatric Hospital; Tokyo Japan

3. Boehringer Ingelheim International GmbH; Ingelheim Germany

4. Eli Lilly and Company; Utrecht Netherlands

5. Diabetes Research Centre; University of Leicester; Leicester UK

Funder

Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.13240/fullpdf

Reference59 articles.

1. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians;McBean;Diabetes Care,2004

2. International Diabetes Federation IDF Diabetes Atlas http://www.diabetesatlas.org

3. The diabetes epidemic in the elderly population in Western Europe: data from population-based studies;Rathmann;Gesundheitswesen,2005

4. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study;Miller;BMJ,2010

5. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study;Huang;JAMA Intern Med,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness and safety of linagliptin within elderly type 2 diabetes mellitus: a meta-analysis and systematic review;Minerva Endocrinology;2022-02

2. Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes;Diabetes & Metabolism;2021-11

3. Efficacy and Cardiovascular Safety of DPP-4 Inhibitors;Current Drug Safety;2021-06-08

4. Careful use to minimize adverse events of oral antidiabetic medications in the elderly;Expert Opinion on Pharmacotherapy;2021-04-13

5. Dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus;The Journal of Dermatology;2021-02-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3